| ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
1 | AN ACT concerning agriculture.
| |||||||||||||||||||
2 | Be it enacted by the People of the State of Illinois,
| |||||||||||||||||||
3 | represented in the General Assembly:
| |||||||||||||||||||
4 | Section 5. The Industrial Hemp Act is amended by adding | |||||||||||||||||||
5 | Section 30 as follows: | |||||||||||||||||||
6 | (505 ILCS 89/30 new) | |||||||||||||||||||
7 | Sec. 30. Hemp extract for human consumption. | |||||||||||||||||||
8 | (a) Definitions. As used in this Section: | |||||||||||||||||||
9 | "Approved source" means an establishment manufacturing | |||||||||||||||||||
10 | products consisting of or containing hemp extract intended for | |||||||||||||||||||
11 | ingestion that meets local, State, or federal regulatory food | |||||||||||||||||||
12 | safety or health standards from the jurisdiction of origin. | |||||||||||||||||||
13 | "Batch" or "lot" means the hemp extract produced during a | |||||||||||||||||||
14 | period of time under similar conditions and identified by a | |||||||||||||||||||
15 | specific code that allows traceability. | |||||||||||||||||||
16 | "Expiration date" means the month and year as determined | |||||||||||||||||||
17 | by the manufacturer, packer, or distributor on the basis of | |||||||||||||||||||
18 | tests or other information showing that the product, until | |||||||||||||||||||
19 | that date, under the conditions of handling, storage, | |||||||||||||||||||
20 | preparation, and use per label directions will, when consumed, | |||||||||||||||||||
21 | contain not less than the quantity of each ingredient as set | |||||||||||||||||||
22 | forth on its label. | |||||||||||||||||||
23 | "Hemp" means the plant Cannabis sativa L. and any part of |
| |||||||
| |||||||
1 | that plant, including the seeds thereof, and all derivatives, | ||||||
2 | extracts, cannabinoids, isomers, acids, salts, or isomers | ||||||
3 | thereof, whether growing or not, that has a total delta-9 | ||||||
4 | tetrahydrocannabinol concentration that does not exceed 0.3% | ||||||
5 | on a dry-weight basis. | ||||||
6 | "Hemp extract" means a substance of compound intended for | ||||||
7 | ingestion that is derived from or contains hemp and that does | ||||||
8 | not contain other controlled substances. | ||||||
9 | "Hemp food establishment" means an establishment as | ||||||
10 | defined in extracting, manufacturing, processing, packing, | ||||||
11 | holding, preparing, or selling hemp Extract intended for human | ||||||
12 | consumption at wholesale or retail. | ||||||
13 | "Hemp extract intended for human consumption" includes | ||||||
14 | products intended for human ingestion or human inhalation, but | ||||||
15 | does not include topical applications. | ||||||
16 | "Ingestion" means the process of consuming hemp extract | ||||||
17 | through the mouth, whether by swallowing into the | ||||||
18 | gastrointestinal system or through tissue absorption. | ||||||
19 | "Inhalation" means the process of consuming hemp extract | ||||||
20 | through the mouth or nasal passages into the respiratory | ||||||
21 | system. | ||||||
22 | "Manufacturing" means preparing or packaging products | ||||||
23 | consisting of or containing hemp extract intended for human | ||||||
24 | consumption. | ||||||
25 | "Processor" or "extractor" means the establishment that | ||||||
26 | removes the hemp extract oil from the hemp plant. |
| |||||||
| |||||||
1 | "Self-service merchandising" means an open display of hemp | ||||||
2 | extract products to which the public has access without the | ||||||
3 | intervention of the vendor or a store employee. | ||||||
4 | "Total delta-9 tetrahydrocannabinol concentration" means | ||||||
5 | delta-9 tetrahydrocannabinol plus 0.877 x | ||||||
6 | tetrahydrocannabinolic acid. | ||||||
7 | "Vending machine" means any self-service device that, upon | ||||||
8 | completion of payment, dispenses hemp extract products without | ||||||
9 | the necessity of replenishing the device between each | ||||||
10 | operation. | ||||||
11 | (b) Hemp extract distributed or sold in violation of this | ||||||
12 | Section shall be considered adulterated or misbranded. Hemp | ||||||
13 | extract intended for human consumption that is not clearly | ||||||
14 | labeled as intended for inhalation or ingestion must meet all | ||||||
15 | of the requirements for hemp products intended for both | ||||||
16 | inhalation and ingestion. If there are different requirements | ||||||
17 | for hemp products intended for inhalation and hemp products | ||||||
18 | intended for ingestion, the stricter standard shall apply. | ||||||
19 | (c) Each establishment distributing products consisting of | ||||||
20 | or containing hemp extract intended for human consumption must | ||||||
21 | be permitted as a hemp food establishment by the Department. | ||||||
22 | The annual permit fee for a hemp food establishment is | ||||||
23 | $650.00. | ||||||
24 | (d) Hemp or hemp extract intended for ingestion must be | ||||||
25 | manufactured by an approved source. A hemp food establishment | ||||||
26 | shall provide a valid hemp food establishment permit and the |
| |||||||
| |||||||
1 | most recent food safety or health inspection report from the | ||||||
2 | approved source to the Department upon request. | ||||||
3 | (e) Hemp or hemp extract intended for inhalation must be | ||||||
4 | manufactured by a source permitted to manufacture hemp or hemp | ||||||
5 | extract intended for inhalation. A hemp food establishment | ||||||
6 | shall provide a valid hemp food establishment permit and the | ||||||
7 | most recent inspection report from the permitting source to | ||||||
8 | the Department upon request. | ||||||
9 | (f) Hemp extract intended for human consumption may not be | ||||||
10 | manufactured, processed, packaged, held, prepared, or sold | ||||||
11 | under Section 4 of the Food Handling Regulation Enforcement | ||||||
12 | Act. | ||||||
13 | (g) Hemp extract intended for human consumption must be | ||||||
14 | packaged in containers minimizing the exposure to light to | ||||||
15 | prevent degradation of the cannabinoids. Containers used for | ||||||
16 | hemp extract intended for human consumption must comply with | ||||||
17 | this requirement. | ||||||
18 | (h) Hemp extract intended for human consumption shall not | ||||||
19 | contain a total delta-9 tetrahydrocannabinol concentration | ||||||
20 | that exceeds 0.3%. | ||||||
21 | (i) Hemp extract intended for human consumption shall not | ||||||
22 | be manufactured, processed, packaged, held, or prepared in a | ||||||
23 | private home or in a room used as living or sleeping quarters. | ||||||
24 | (j) Hemp extract intended for human consumption shall not | ||||||
25 | be offered for sale by means of vending machines. | ||||||
26 | (k) Products intended for human consumption shall be |
| |||||||
| |||||||
1 | considered adulterated if contaminants are detected at levels | ||||||
2 | greater than the limits listed in this Section. Contaminant | ||||||
3 | limits under this Section do not constitute authorization to | ||||||
4 | use or apply any of the following contaminants during hemp | ||||||
5 | cultivation or processing. | ||||||
6 | (1) The following substances are prohibited in Hemp | ||||||
7 | extract intended for inhalation: | ||||||
8 | (A) Abamectin, 300 parts per billion for | ||||||
9 | Ingestion; 100 parts per billion for Inhalation. | ||||||
10 | (B) Acephate, 3,000 parts per billion for | ||||||
11 | Ingestion; 100 parts per billion for Inhalation. | ||||||
12 | (C) Acequinocyl, 2,000 parts per billion for | ||||||
13 | Ingestion; 100 parts per billion for Inhalation. | ||||||
14 | (D) Acetamiprid, 3,000 parts per billion for | ||||||
15 | Ingestion; 100 parts per billion for Inhalation. | ||||||
16 | (E) Aldicarb, 100 parts per billion for Ingestion | ||||||
17 | or Inhalation. | ||||||
18 | (F) Azoxystrobin, 3,000 parts per billion for | ||||||
19 | Ingestion; 100 parts per billion for Inhalation. | ||||||
20 | (G) Bifenazate, 3,000 parts per billion for | ||||||
21 | Ingestion; 100 parts per billion for Inhalation. | ||||||
22 | (H) Bifenthrin, 500 parts per billion for | ||||||
23 | Ingestion; 100 parts per billion for Inhalation. | ||||||
24 | (I) Boscalid, 3,000 parts per billion for | ||||||
25 | Ingestion; 100 parts per billion for Inhalation. | ||||||
26 | (J) Captan, 3,000 parts per billion for Ingestion; |
| |||||||
| |||||||
1 | 700 parts per billion for Inhalation. | ||||||
2 | (K) Carbaryl, 500 parts per billion for Ingestion; | ||||||
3 | 500 parts per billion for Inhalation. | ||||||
4 | (L) Carbofuran, 100 parts per billion for | ||||||
5 | Ingestion or Inhalation. | ||||||
6 | (M) Chlorantraniliprole, 3,000 parts per billion | ||||||
7 | for Ingestion; 1,000 parts per billion for Inhalation. | ||||||
8 | (N) Chlordane, 100 parts per billion for Ingestion | ||||||
9 | or Inhalation. | ||||||
10 | (O) Chlorfenapyr, 100 parts per billion for | ||||||
11 | Ingestion or Inhalation. | ||||||
12 | (P) Chlormequat chloride, 3,000 parts per billion | ||||||
13 | for Ingestion; 1,000 parts per billion for Inhalation. | ||||||
14 | (Q) Chlorpyrifos, 100 parts per billion for | ||||||
15 | Ingestion or Inhalation. | ||||||
16 | (R) Clofentezine, 500 parts per billion for | ||||||
17 | Ingestion; 200 parts per billion for Inhalation. | ||||||
18 | (S) Coumaphos, 100 parts per billion for Ingestion | ||||||
19 | or Inhalation. | ||||||
20 | (T) Cyfluthrin, 1,000 parts per billion for | ||||||
21 | Ingestion; 500 parts per billion for Inhalation. | ||||||
22 | (U) Cypermethrin, 1,000 parts per billion for | ||||||
23 | Ingestion; 500 parts per billion for Inhalation. | ||||||
24 | (V) Daminozide, 100 parts per billion for | ||||||
25 | Ingestion or Inhalation. | ||||||
26 | (W) DDVP (Dichlorvos), 100 parts per billion for |
| |||||||
| |||||||
1 | Ingestion or Inhalation. | ||||||
2 | (X) Diazinon, 200 parts per billion for Ingestion; | ||||||
3 | 100 parts per billion for Inhalation. | ||||||
4 | (Y) Dimethoate, 100 parts per billion for | ||||||
5 | Ingestion or Inhalation. | ||||||
6 | (Z) Dimethomorph, 3,000 parts per billion for | ||||||
7 | Ingestion; 200 parts per billion for Inhalation. | ||||||
8 | (AA) Ethoprop(hos), 100 parts per billion for | ||||||
9 | Ingestion or Inhalation. | ||||||
10 | (BB) Etofenprox, 100 parts per billion for | ||||||
11 | Ingestion or Inhalation. | ||||||
12 | (CC) Etoxazole, 1,500 parts per billion for | ||||||
13 | Ingestion; 100 parts per billion for Inhalation. | ||||||
14 | (DD) Fenhexamid, 3,000 parts per billion for | ||||||
15 | Ingestion; 100 parts per billion for Inhalation. | ||||||
16 | (EE) Fenoxycarb, 100 parts per billion for | ||||||
17 | Ingestion or Inhalation. | ||||||
18 | (FF) Fenpyroximate, 2,000 parts per billion for | ||||||
19 | Ingestion; 100 parts per billion for Inhalation. | ||||||
20 | (GG) Fipronil, 100 parts per billion for Ingestion | ||||||
21 | or Inhalation. | ||||||
22 | (HH) Flonicamid, 2,000 parts per billion for | ||||||
23 | Ingestion; 100 parts per billion for Inhalation. | ||||||
24 | (II) Fludioxonil, 3,000 parts per billion for | ||||||
25 | Ingestion; 100 parts per billion for Inhalation. | ||||||
26 | (JJ) Hexythiazox, 2,000 parts per billion for |
| |||||||
| |||||||
1 | Ingestion; 100 parts per billion for Inhalation. | ||||||
2 | (KK) Imazalil, 100 parts per billion for Ingestion | ||||||
3 | or Inhalation. | ||||||
4 | (LL) Imidacloprid, 3,000 parts per billion for | ||||||
5 | Ingestion; 400 parts per billion for Inhalation. | ||||||
6 | (MM) Kresoxim-methyl, 1,000 parts per billion for | ||||||
7 | Ingestion; 100 parts per billion for Inhalation. | ||||||
8 | (NN) Malathion, 2,000 parts per billion for | ||||||
9 | Ingestion; 200 parts per billion for Inhalation. | ||||||
10 | (OO) Metalaxyl, 3,000 parts per billion for | ||||||
11 | Ingestion; 100 parts per billion for Inhalation. | ||||||
12 | (PP) Methiocarb, 100 parts per billion for | ||||||
13 | Ingestion or Inhalation. | ||||||
14 | (QQ) Methomyl, 100 parts per billion for Ingestion | ||||||
15 | or Inhalation. | ||||||
16 | (RR) Methyl parathion, 100 parts per billion for | ||||||
17 | Ingestion or Inhalation. | ||||||
18 | (SS) Mevinphos, 100 parts per billion for | ||||||
19 | Ingestion or Inhalation. | ||||||
20 | (TT) Myclobutanil, 3,000 parts per billion for | ||||||
21 | Ingestion; prohibited at any concentration for | ||||||
22 | Inhalation. | ||||||
23 | (UU) Naled, 500 parts per billion for Ingestion; | ||||||
24 | 250 parts per billion for Inhalation. | ||||||
25 | (VV) Oxamyl, 500 parts per billion for Ingestion | ||||||
26 | or Inhalation. |
| |||||||
| |||||||
1 | (WW) Paclobutrazol, 100 parts per billion for | ||||||
2 | Ingestion or Inhalation. | ||||||
3 | (XX) Pentachloronitrobenzene, 200 parts per | ||||||
4 | billion for Ingestion; 150 parts per billion for | ||||||
5 | Inhalation. | ||||||
6 | (YY) Permethrin, 1,000 parts per billion for | ||||||
7 | Ingestion; 100 parts per billion for Inhalation. | ||||||
8 | (ZZ) Phosmet, 200 parts per billion for Ingestion; | ||||||
9 | 100 parts per billion for Inhalation. | ||||||
10 | (AAA) Piperonyl butoxide, 3,000 parts per billion | ||||||
11 | for Ingestion or Inhalation. | ||||||
12 | (BBB) Prallethrin, 400 parts per billion for | ||||||
13 | Ingestion; 100 parts per billion for Inhalation. | ||||||
14 | (CCC) Propiconazole, 1,000 parts per billion for | ||||||
15 | Ingestion; 100 parts per billion for Inhalation. | ||||||
16 | (DDD) Propoxur, 100 parts per billion for | ||||||
17 | Ingestion or Inhalation. | ||||||
18 | (EEE) Pyrethrins, 1,000 parts per billion for | ||||||
19 | Ingestion; 500 parts per billion for Inhalation. | ||||||
20 | (FFF) Pyridaben, 3,000 parts per billion for | ||||||
21 | Ingestion; 200 parts per billion for Inhalation. | ||||||
22 | (GGG) Spinetoram, 3,000 parts per billion for | ||||||
23 | Ingestion; 200 parts per billion for Inhalation. | ||||||
24 | (HHH) Spinosad A & D, 3,000 parts per billion for | ||||||
25 | Ingestion; 100 parts per billion for Inhalation. | ||||||
26 | (III) Spiromesifen, 3,000 parts per billion for |
| |||||||
| |||||||
1 | Ingestion; 100 parts per billion for Inhalation. | ||||||
2 | (JJJ) Spirotetramat, 3,000 parts per billion for | ||||||
3 | Ingestion; 100 parts per billion for Inhalation. | ||||||
4 | (KKK) Spiroxamine, 100 parts per billion for | ||||||
5 | Ingestion or Inhalation. | ||||||
6 | (LLL) Tebuconazole, 1,000 parts per billion for | ||||||
7 | Ingestion; 100 parts per billion for Inhalation. | ||||||
8 | (MMM) Thiacloprid, 100 parts per billion for | ||||||
9 | Ingestion; 100 parts per billion for Inhalation. | ||||||
10 | (NNN) Thiamethoxam, 1,000 parts per billion for | ||||||
11 | Ingestion; 500 parts per billion for Inhalation. | ||||||
12 | (OOO) Trifloxystrobin, 3,000 parts per billion for | ||||||
13 | Ingestion; 100 parts per billion for Inhalation. | ||||||
14 | (3) Residual solvent limits for ingestion or | ||||||
15 | inhalation: | ||||||
16 | (A) 1,2-Dichloroethane, 2 parts per million. | ||||||
17 | (B) 1,1-Dichloroethene, 8 parts per million. | ||||||
18 | (C) Acetone, 750 parts per million. | ||||||
19 | (D) Acetonitrile, 60 parts per million. | ||||||
20 | (E) Benzene, 1 part per million. | ||||||
21 | (F) Butane, 5,000 parts per million. | ||||||
22 | (G) Chloroform, 2 parts per million. | ||||||
23 | (H) Ethanol, 5,000 parts per million. | ||||||
24 | (I) Ethyl Acetate, 400 parts per million. | ||||||
25 | (J) Ethyl Ether, 500 parts per million. | ||||||
26 | (K) Ethylene Oxide, 5 parts per million. |
| |||||||
| |||||||
1 | (L) Heptane, 5,000 parts per million. | ||||||
2 | (M) Hexane, 250 parts per million. | ||||||
3 | (N) Isopropyl Alcohol, 500 parts per million. | ||||||
4 | (O) Methanol, 250 parts per million. | ||||||
5 | (P) Methylene Chloride, 125 parts per million. | ||||||
6 | (Q) Pentane, 750 parts per million. | ||||||
7 | (R) Propane, 5,000 parts per million. | ||||||
8 | (S) Toluene, 150 parts per million. | ||||||
9 | (T) Trichloroethylene 25 parts per million. | ||||||
10 | (U) Xylenes, Total (ortho-, meta-, para-), 150 | ||||||
11 | parts per million. | ||||||
12 | (4) Metals limits: | ||||||
13 | (A) Cadmium, 500 parts per billion for ingestion; | ||||||
14 | 200 parts per billion for inhalation. | ||||||
15 | (B) Lead, 500 parts per billion for ingestion or | ||||||
16 | inhalation. | ||||||
17 | (C) Arsenic, 1,500 parts per billion for | ||||||
18 | ingestion; 200 parts per billion for inhalation. | ||||||
19 | (D) Mercury, 3,000 parts per billion for | ||||||
20 | ingestion; 200 parts per billion for inhalation. | ||||||
21 | (5) Biological limits for ingestion or inhalation: | ||||||
22 | (A) Shiga toxin-producing Escherichia coli (STEC | ||||||
23 | E. coli) and other pathogenic E. coli, 1 CFU per gram. | ||||||
24 | (B) Salmonella, 1 CFU per gram. | ||||||
25 | (C) Aspergillus niger, Aspergillus fumigatus, | ||||||
26 | Aspergillus flavus, Aspergillus terreus, 1 CFU per |
| |||||||
| |||||||
1 | gram. | ||||||
2 | (6) Mycotoxin limits: | ||||||
3 | (A) Total Aflatoxin (B1, B2, G1, G2), 20 parts per | ||||||
4 | billion for ingestion or inhalation. | ||||||
5 | (B) Ochratoxin, 20 parts per billion for ingestion | ||||||
6 | or inhalation. | ||||||
7 | (7) Total combined yeast and mold limit: 100,000 CFU | ||||||
8 | per gram for ingestion or inhalation. | ||||||
9 | (8) Cannabinoid limits: total delta-9 | ||||||
10 | tetrahydrocannabinol concentration shall not exceed 0.3%. | ||||||
11 | (9) If a testing sample is found to contain levels of | ||||||
12 | any pathogen, toxicant, residual solvent, metal, or | ||||||
13 | pesticide not enumerated in this Section or by State law, | ||||||
14 | then the hemp extract shall be considered adulterated. | ||||||
15 | (10) Devices used during the inhalation process must | ||||||
16 | not introduce contaminants over the limits listed in this | ||||||
17 | Section into the hemp extract product. | ||||||
18 | (l) Hemp extract intended for human consumption must be | ||||||
19 | labeled as follows: | ||||||
20 | (1) If cannabinoids are marketed, the number of | ||||||
21 | milligrams of each cannabinoid per serving and the | ||||||
22 | serving size must be declared on the label. | ||||||
23 | (2) The label and advertisement shall not contain | ||||||
24 | claims indicating the product is intended for | ||||||
25 | diagnosis, cure, mitigation, treatment, or prevention | ||||||
26 | of disease; and if such claims are included, then the |
| |||||||
| |||||||
1 | product shall be considered misbranded. | ||||||
2 | (3) Hemp extract intended solely for inhalation | ||||||
3 | must be clearly labeled with the statement, "Not | ||||||
4 | Intended For Ingestion – Do Not Eat.". | ||||||
5 | (m) Disposal. | ||||||
6 | (1) Laboratory samples found to contain more than | ||||||
7 | a total delta-9 tetrahydrocannabinol concentration of | ||||||
8 | 0.3% shall be disposed of. | ||||||
9 | (2) Hemp extract intended for human consumption | ||||||
10 | containing a total delta-9 tetrahydrocannabinol | ||||||
11 | concentration that exceeds 0.3% shall be detained. | ||||||
12 | Hemp extract intended for human consumption containing | ||||||
13 | a total delta-9 tetrahydrocannabinol concentration | ||||||
14 | that exceeds 0.3% that has been detained shall not be | ||||||
15 | further subdivided or renumbered such that the | ||||||
16 | integrity of the lot is not maintained. The | ||||||
17 | establishment shall not dispose of the hemp extract | ||||||
18 | intended for human consumption in any manner until | ||||||
19 | written permission is given by the Department or a | ||||||
20 | court of competent jurisdiction. | ||||||
21 | (3) Upon receipt of written permission by the | ||||||
22 | Department or a court of competent jurisdiction, the | ||||||
23 | hemp extract intended for human consumption shall be | ||||||
24 | disposed of in a manner approved by a court of | ||||||
25 | competent jurisdiction. | ||||||
26 | (n) Age limit for hemp extract intended for inhalation. |
| |||||||
| |||||||
1 | (1) Any retailer that sells hemp extract intended | ||||||
2 | for inhalation shall post a clear and conspicuous sign | ||||||
3 | directly adjacent to the display of the product that | ||||||
4 | states the following: "THE SALE OF HEMP EXTRACT | ||||||
5 | INTENDED FOR INHALATION TO PERSONS UNDER THE AGE OF 21 | ||||||
6 | IS PROHIBITED. PROOF OF AGE IS REQUIRED FOR | ||||||
7 | PURCHASE.". | ||||||
8 | (2) Hemp extract intended for inhalation may not | ||||||
9 | be mailed, shipped, or otherwise delivered to a | ||||||
10 | purchaser unless, before the delivery to the | ||||||
11 | purchaser, the hemp food establishment obtains | ||||||
12 | confirmation that the purchaser is 21 years of age or | ||||||
13 | older. | ||||||
14 | (3) Hemp food establishments shall require proof | ||||||
15 | of age from a purchaser of any product containing hemp | ||||||
16 | extract intended for inhalation before selling the | ||||||
17 | product to that person. Hemp food establishments shall | ||||||
18 | exercise diligence in the management and supervision | ||||||
19 | of their premises and in the supervision and training | ||||||
20 | of their employees to prevent the underage sale of | ||||||
21 | these products. | ||||||
22 | (4) Hemp extract intended for inhalation shall not | ||||||
23 | be offered for sale by means of self-service | ||||||
24 | merchandising unless proof of age has been verified | ||||||
25 | before allowing access to the self-service | ||||||
26 | merchandising. |
| |||||||
| |||||||
1 | (5) The giving or sampling of hemp extract | ||||||
2 | intended for inhalation products by a hemp food | ||||||
3 | establishment to any person under the age of 21 is | ||||||
4 | prohibited. | ||||||
5 | (o) Penalties. | ||||||
6 | (1) Hemp or hemp extract products must meet the | ||||||
7 | requirements of this Section. Hemp or hemp extract | ||||||
8 | products that do not meet the requirements of this | ||||||
9 | Section or without the documentation required in this | ||||||
10 | Section may not be sold in this State. | ||||||
11 | (2) Violations of this Section shall result in the | ||||||
12 | imposition of stop-sale or stop-use orders, an | ||||||
13 | administrative fine of up to $5,000 per violation, | ||||||
14 | permit suspension, permit revocation, or any | ||||||
15 | combination of those penalties. | ||||||
16 | (3) The sale of hemp extract intended for | ||||||
17 | inhalation to persons under the age of 21 shall result | ||||||
18 | in an administrative fine of $5,000 per occurrence.
|